Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.

Acrobiosystems Co Ltd is a China-based company specializing in providing recombinant protein and other key biological reagent products and technical services. The Company's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The Company's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.